Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

133.06
Delayed Data
As of 12:09pm ET
 -1.85 / -1.37%
Today’s Change
124.35
Today|||52-Week Range
173.00
-10.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues250.8M237.7M244.2M215.3M
 
 
 
 
 
Cost of Goods Sold48.7M40.3M40.7M39.6M
 
 
 
 
 
Depreciation And Amortization4.0M3.9M3.9M3.9M
 
 
 
 
 
 
Operating ExpensesGross Income198.1M193.5M199.6M171.8M
 
 
 
 
 
General Expenses35.5M34.2M46.1M37.4M
 
 
 
 
 
Research And Development13.8M12.8M23.9M14.5M
 
 
 
 
 
Total Operating Expenses88.3M78.4M90.6M80.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income162.6M159.3M153.5M134.4M
 
 
 
 
 
Extraordinary Charge-2.3M------
 
 
Other Expenses7.7M8.6M32.9M-3.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income170.0M170.9M189.5M133.8M
 
 
 
 
 
Income Taxes-26.1M-28.2M-36.9M-30.1M
 
 
 
 
 
Minority Interest-319.0K-132.0K-26.0K-37.0K
 
 
 
 
 
Discontinued Operations-223.0K-126.0K-314.0K-31.0K
 
 
 
 
 
Net Income143.4M142.5M152.3M103.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M42.8M42.8M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M42.8M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS$3.35$3.33$3.56$2.42
 
 
 
 
 
EPS Diluted$3.35$3.33$3.56$2.42